JPWO2022014680A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022014680A5
JPWO2022014680A5 JP2022536446A JP2022536446A JPWO2022014680A5 JP WO2022014680 A5 JPWO2022014680 A5 JP WO2022014680A5 JP 2022536446 A JP2022536446 A JP 2022536446A JP 2022536446 A JP2022536446 A JP 2022536446A JP WO2022014680 A5 JPWO2022014680 A5 JP WO2022014680A5
Authority
JP
Japan
Prior art keywords
octan
azabicyclo
represented
formula
fluoropyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022536446A
Other languages
English (en)
Japanese (ja)
Other versions
JP7190612B2 (ja
JPWO2022014680A1 (cg-RX-API-DMAC10.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/026649 external-priority patent/WO2022014680A1/ja
Publication of JPWO2022014680A1 publication Critical patent/JPWO2022014680A1/ja
Application granted granted Critical
Publication of JP7190612B2 publication Critical patent/JP7190612B2/ja
Publication of JPWO2022014680A5 publication Critical patent/JPWO2022014680A5/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022536446A 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途 Active JP7190612B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020122864 2020-07-17
JP2020122864 2020-07-17
PCT/JP2021/026649 WO2022014680A1 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Publications (3)

Publication Number Publication Date
JPWO2022014680A1 JPWO2022014680A1 (cg-RX-API-DMAC10.html) 2022-01-20
JP7190612B2 JP7190612B2 (ja) 2022-12-15
JPWO2022014680A5 true JPWO2022014680A5 (cg-RX-API-DMAC10.html) 2022-12-16

Family

ID=79291962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022536446A Active JP7190612B2 (ja) 2020-07-17 2021-07-15 置換ピペリジン化合物及びその用途

Country Status (32)

Country Link
US (1) US11479552B2 (cg-RX-API-DMAC10.html)
EP (1) EP4151277B1 (cg-RX-API-DMAC10.html)
JP (1) JP7190612B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230040953A (cg-RX-API-DMAC10.html)
CN (3) CN119235864A (cg-RX-API-DMAC10.html)
AR (1) AR122973A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021308053A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022026161A2 (cg-RX-API-DMAC10.html)
CA (1) CA3187835A1 (cg-RX-API-DMAC10.html)
CL (1) CL2022003666A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022018446A2 (cg-RX-API-DMAC10.html)
DK (1) DK4151277T3 (cg-RX-API-DMAC10.html)
ES (1) ES3067008T3 (cg-RX-API-DMAC10.html)
FI (1) FI4151277T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260428T1 (cg-RX-API-DMAC10.html)
IL (1) IL299125B2 (cg-RX-API-DMAC10.html)
JO (1) JOP20220345A1 (cg-RX-API-DMAC10.html)
LT (1) LT4151277T (cg-RX-API-DMAC10.html)
MA (1) MA59554B1 (cg-RX-API-DMAC10.html)
MD (1) MD4151277T2 (cg-RX-API-DMAC10.html)
MX (1) MX2022016388A (cg-RX-API-DMAC10.html)
PE (1) PE20231103A1 (cg-RX-API-DMAC10.html)
PH (1) PH12022553488A1 (cg-RX-API-DMAC10.html)
PL (1) PL4151277T3 (cg-RX-API-DMAC10.html)
PT (1) PT4151277T (cg-RX-API-DMAC10.html)
RS (1) RS67943B1 (cg-RX-API-DMAC10.html)
SI (1) SI4151277T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202600159T1 (cg-RX-API-DMAC10.html)
TW (2) TWI888599B (cg-RX-API-DMAC10.html)
UA (1) UA129636C2 (cg-RX-API-DMAC10.html)
WO (1) WO2022014680A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202213562B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20260083444A (ko) 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
JP7833486B2 (ja) 2021-05-26 2026-03-19 アルカーメス,インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
JP7591592B2 (ja) * 2022-01-14 2024-11-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物を含有する医薬
WO2023136279A1 (ja) * 2022-01-14 2023-07-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 置換ピペリジン化合物の結晶並びに置換ピペリジン化合物の塩及びそれらの結晶
EP4600242A1 (en) * 2022-10-07 2025-08-13 Kissei Pharmaceutical Co., Ltd. Cyclopentane compound
TW202432109A (zh) * 2022-10-31 2024-08-16 日商武田藥品工業股份有限公司 食慾素2型受體促效劑之給藥
JPWO2024128305A1 (cg-RX-API-DMAC10.html) 2022-12-16 2024-06-20
TW202502342A (zh) 2023-06-02 2025-01-16 日商武田藥品工業股份有限公司 食慾素2受體促效劑用於改善睡眠期間之呼吸功能的用途
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists
WO2025137359A1 (en) 2023-12-20 2025-06-26 Eisai R&D Management Co., Ltd. Assay methods to identify a disease
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
EP0828751A4 (en) 1995-05-05 1999-01-20 Human Genome Sciences Inc HUMAN NEUROPEPTIDE RECEPTOR
US6309854B1 (en) 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US5935814A (en) 1997-04-30 1999-08-10 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72Y receptor
US6020157A (en) 1997-04-30 2000-02-01 Smithkline Beecham Corporation Polynucleotides encoding HFGAN72X receptor
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
WO2005028438A1 (ja) 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
AU2005298693A1 (en) * 2004-10-20 2006-05-04 Neurosearch A/S Novel diazabicyclic aryl derivatives and their medical use
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
TW201444849A (zh) * 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途

Similar Documents

Publication Publication Date Title
JP2025094100A5 (cg-RX-API-DMAC10.html)
JP2006526031A5 (cg-RX-API-DMAC10.html)
JP2023534131A5 (cg-RX-API-DMAC10.html)
JP2010513478A5 (cg-RX-API-DMAC10.html)
JP2023116721A5 (cg-RX-API-DMAC10.html)
JP2021530451A5 (cg-RX-API-DMAC10.html)
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2021518134A5 (cg-RX-API-DMAC10.html)
PE20231103A1 (es) Compuestos de piperidina sustituida y su uso
JP2024050603A5 (cg-RX-API-DMAC10.html)
JP2010507641A5 (cg-RX-API-DMAC10.html)
JP2009530282A5 (cg-RX-API-DMAC10.html)
JP2022538215A5 (cg-RX-API-DMAC10.html)
JP2023524547A5 (cg-RX-API-DMAC10.html)
TWD205549S (zh) 固態硬碟
JP2009502743A5 (cg-RX-API-DMAC10.html)
JP2022116141A5 (cg-RX-API-DMAC10.html)
JP2022166039A5 (cg-RX-API-DMAC10.html)
JP2008526830A5 (cg-RX-API-DMAC10.html)
JP2008514563A5 (cg-RX-API-DMAC10.html)
JP2007302683A5 (cg-RX-API-DMAC10.html)
IL294247B2 (en) (2r,4r)-1-(3-chloro-2-fluorobenzyl)-4-((5-fluoro-4-methyl-6-((5-methyl-1h-pyrazol-3-yl)amino)pyridin-2-yl)methyl)-2-methylpiperidine-4-carboxylic acid and a pharmaceutical composition comprising the compound or pharmaceutically acceptable salt thereof
JP2012533601A5 (cg-RX-API-DMAC10.html)
WO2021127097A3 (en) Organic-based nicotine gel compositions
JP2023508938A5 (cg-RX-API-DMAC10.html)